507 related articles for article (PubMed ID: 29037469)
21. [Long-term outcome of neoadjuvant radiochemotherapy followed by surgery for esophageal cancer: a single institution retrospective study of 102 patients].
Ruffier-Loubière A; Janoray G; Chapet S; de Calan L; Dumont P; Dorval É; Orain I; Calais G
Cancer Radiother; 2015 Aug; 19(5):322-30. PubMed ID: 26215366
[TBL] [Abstract][Full Text] [Related]
22. Patterns of recurrence after trimodality therapy for esophageal cancer.
Dorth JA; Pura JA; Palta M; Willett CG; Uronis HE; D'Amico TA; Czito BG
Cancer; 2014 Jul; 120(14):2099-105. PubMed ID: 24711267
[TBL] [Abstract][Full Text] [Related]
23. Circulating Tumor DNA Analysis for Detection of Minimal Residual Disease After Chemoradiotherapy for Localized Esophageal Cancer.
Azad TD; Chaudhuri AA; Fang P; Qiao Y; Esfahani MS; Chabon JJ; Hamilton EG; Yang YD; Lovejoy A; Newman AM; Kurtz DM; Jin M; Schroers-Martin J; Stehr H; Liu CL; Hui AB; Patel V; Maru D; Lin SH; Alizadeh AA; Diehn M
Gastroenterology; 2020 Feb; 158(3):494-505.e6. PubMed ID: 31711920
[TBL] [Abstract][Full Text] [Related]
24. Role of neoadjuvant therapy for esophageal adenocarcinoma.
Ku GY; Ilson DH
Surg Oncol Clin N Am; 2009 Jul; 18(3):533-46. PubMed ID: 19500742
[TBL] [Abstract][Full Text] [Related]
25. Comparative study between endoscopic ultrasonography and positron emission tomography-computed tomography in staging patients with esophageal squamous cell carcinoma.
Yen TJ; Chung CS; Wu YW; Yen RF; Cheng MF; Lee JM; Hsu CH; Chang YL; Wang HP
Dis Esophagus; 2012 Jan; 25(1):40-7. PubMed ID: 21595776
[TBL] [Abstract][Full Text] [Related]
26. [A prospective comparison between surgery alone and postoperative chemoradiotherapy for locally advanced esophageal squamous cell carcinoma].
Cao XF; Lü J; Zhu B; An HY; Wang S; Wu BC; Ji L; Tao L; Wang DD
Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):452-5. PubMed ID: 20819489
[TBL] [Abstract][Full Text] [Related]
27. New therapeutic strategies for squamous cell cancer and adenocarcinoma.
Wijnhoven BPL; Toxopeus ELA; Vallböhmer D; Knoefel WT; Krasna MJ; Perez K; van Rossum PSN; Ruurda JP; van Hillegersberg R; Schiesser M; Schneider P; Felix VN
Ann N Y Acad Sci; 2013 Oct; 1300():213-225. PubMed ID: 24117644
[TBL] [Abstract][Full Text] [Related]
28. Oesophageal cancer.
Lagergren J; Smyth E; Cunningham D; Lagergren P
Lancet; 2017 Nov; 390(10110):2383-2396. PubMed ID: 28648400
[TBL] [Abstract][Full Text] [Related]
29. Complications during neoadjuvant therapy and prognosis following surgery for esophageal cancer.
Markar SR; Johar A; Maisey N; Lagergren P; Lagergren J
Dis Esophagus; 2018 May; 31(5):. PubMed ID: 29293984
[TBL] [Abstract][Full Text] [Related]
30. Reduced incidence of nodal micrometastasis after major response to neoadjuvant chemoradiation in locally advanced esophageal cancer.
Prenzel KL; König A; Schneider PM; Schnickmann C; Baldus SE; Schröder W; Bollschweiler E; Dienes HP; Mueller RP; Izbicki JR; Hölscher AH
Ann Surg Oncol; 2007 Feb; 14(2):954-9. PubMed ID: 17103071
[TBL] [Abstract][Full Text] [Related]
31. The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy.
Cerfolio RJ; Bryant AS; Ohja B; Bartolucci AA; Eloubeidi MA
J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1232-41. PubMed ID: 15942562
[TBL] [Abstract][Full Text] [Related]
32. Systematic review and network meta-analysis: neoadjuvant chemoradiotherapy for locoregional esophageal cancer.
Huang TC; Hsu CH; Lin CC; Tu YK
Jpn J Clin Oncol; 2015 Nov; 45(11):1023-8. PubMed ID: 26246479
[TBL] [Abstract][Full Text] [Related]
33. Definitive chemoradiation for locoregional recurrences of esophageal cancer after primary curative treatment.
Jeene PM; Versteijne E; van Berge Henegouwen MI; Bergmann JJ; Geijsen ED; Muller K; van Laarhoven HW; Hulshof MC
Dis Esophagus; 2017 Feb; 30(2):1-5. PubMed ID: 27766725
[TBL] [Abstract][Full Text] [Related]
34. Treatment strategies for esophageal cancer.
Nieman DR; Peters JH
Gastroenterol Clin North Am; 2013 Mar; 42(1):187-97. PubMed ID: 23452638
[TBL] [Abstract][Full Text] [Related]
35. Longitudinal analysis of cytokine expression during neoadjuvant chemoradiotherapy and subsequent surgery in esophageal cancer patients.
Bosch DJ; Wang D; Nijsten MW; Mul VE; Hospers GA; Burgerhof JG; Struys MM; Plukker JT
Am J Surg; 2016 Jul; 212(1):89-95. PubMed ID: 27036621
[TBL] [Abstract][Full Text] [Related]
36. [Current diagnosis and therapy of esophageal carcinoma].
Mühr-Wilkenshoff F; Stahl M; Faiss S; Zeitz M; Scherübl H
Z Gastroenterol; 2004 Jul; 42(7):615-21. PubMed ID: 15248111
[TBL] [Abstract][Full Text] [Related]
37. Combined Modality Therapy for Management of Esophageal Cancer: Current Approach Based on Experiences from East and West.
Moaven O; Wang TN
Surg Clin North Am; 2019 Jun; 99(3):479-499. PubMed ID: 31047037
[TBL] [Abstract][Full Text] [Related]
38. Neoadjuvant chemotherapy or chemoradiotherapy for locally advanced esophageal cancer.
Smithers BM; Thomson I
Thorac Surg Clin; 2013 Nov; 23(4):509-23. PubMed ID: 24199701
[TBL] [Abstract][Full Text] [Related]
39. Introduction: Esophageal Adenocarcinoma: Updates of Current Status.
Lam AK
Methods Mol Biol; 2018; 1756():1-6. PubMed ID: 29600355
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of progression prior to surgery after neoadjuvant chemoradiotherapy with computed tomography in esophageal cancer patients.
Hulshoff JB; Smit JK; van der Jagt EJ; Plukker JT
Am J Surg; 2014 Jul; 208(1):73-9. PubMed ID: 24476969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
